Figures & data
Table 1. Clinical practice and treatment guidelines for ALS in Japan, the United States, and Europe.
Table 2. Demographics and baseline characteristics for ALS in Japan, the United States, and Europe.
Table 3a. Comparison of demographics and baseline characteristics between reference studies (Placebo group).
Table 3b. Comparison of demographics and baseline characteristics between edaravone studies (Placebo group).
Table 4a. Slope of time dependent change in ALSFRS-R score between reference studies (Placebo group).
Table 4b. Slope of time dependent change in ALSFRS-R score between edaravone studies (Placebo group).